Edgewise Therapeutics, Inc. (EWTX)

34.43 +1.31 (+3.96%) USD  |  NASDAQ  |  Apr 17, 16:00
34.40 -0.03 (-0.09%) Pre-Market: 08:30
More

Edgewise Therapeutics SG&A Expense (Quarterly) : 12.38M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for EWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Glaukos Corp. 94.70M
Nuvalent, Inc. 34.43M
Boston Scientific Corp. 1.834B
Edwards Lifesciences Corp. 602.90M
Eli Lilly & Co. 3.132B